| Bioactivity | hFSH-β-(33-53) TFA, a thiol-containing peptide which corresponds to a second FSH receptor-binding domain, is a FSHR (follicle-stimulating hormone receptor) antagonist. hFSH-β-(33-53) TFA inhibits binding of FSH to receptor and is a partial agonist of estradiol synthesis in Sertoli cells[1][2][3]. | ||||||
| Name | hFSH-β-(33-53) (TFA) | ||||||
| Shortening | YTRDLVYKDPARPKIQKTCTF | ||||||
| Formula | C₁₁₇H₁₈₄F₃N₃₁O₃₄S | ||||||
| Molar Mass | 2657.96 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
hFSH-β-(33-53) (TFA)
CAS: F: C₁₁₇H₁₈₄F₃N₃₁O₃₄S W: 2657.96
hFSH-β-(33-53) TFA, a thiol-containing peptide which corresponds to a second FSH receptor-binding domain, is a FSHR (fo
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.